Showing results (181-190 of 201) with videos related to

Sort By:
Pageof 21
Marine Environmental Research|September 11, 2025
On the diurnal-semidiurnal cycles of physical and biological inter-processes in the upper water column of Reloncaví Sound, northern PatagoniaIván Pérez-Santos, Patricio A Díaz, Lauren Ross, et al.
Science Advances|May 8, 2026
PARP2 deficiency impairs pancreatic cancer progression by promoting genomic instability and antitumor immunityNeus Martínez-Bosch, Noemí Manero-Rupérez, Núria Vázquez-Bellón, et al.
Blood|August 6, 2021
Distinct roles for PARP-1 and PARP-2 in c-Myc-driven B-cell lymphoma in miceMiguel A Galindo-Campos, Nura Lutfi, Sarah Bonnin, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2025
Nuclear Galectin-1 promotes KRAS-dependent activation of pancreatic cancer stellate cellsJudith Vinaixa, Neus Martínez-Bosch, Joan Gibert, et al.
Nature|August 17, 2018
Autism-like phenotype and risk gene mRNA deadenylation by CPEB4 mis-splicingAlberto Parras, Héctor Anta, María Santos-Galindo, et al.
Cells|March 29, 2023
Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive BiomarkerNeus Martínez-Bosch, Noelia Vilariño, Francesc Alameda, et al.
Cancer Epidemiology|August 17, 2015
Trends in survival of multiple myeloma: a thirty-year population-based study in a single institutionRafael Ríos-Tamayo, María José Sánchez, José Manuel Puerta, et al.
Environmental Microbiology|March 7, 2019
Sinorhizobium fredii HH103 nolR and nodD2 mutants gain capacity for infection thread invasion of Lotus japonicus Gifu and Lotus burttiiSebastián Acosta-Jurado, Dulce-Nombre Rodríguez-Navarro, Yasuyuki Kawaharada, et al.
Science Translational Medicine|September 29, 2021
CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington's diseaseSara Picó, Alberto Parras, María Santos-Galindo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 8, 2024
Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based TreatmentSara Cabrero-de Las Heras, Xavier Hernández-Yagüe, Andrea González, et al.
Pageof 21